secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0000950170-24-114481
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galecto appoints Dr. Amy Wechsler to Board of Directors effective October 11, 2024
--------------------------------------------------------------------------------

- Board expanded to seven members; Wechsler appointed as Class I director with term through 2027 annual meeting.
- Wechsler is board-certified in dermatology and psychiatry and serves on the Bausch Health board.
- She holds an M.D. from Cornell University Medical College and an M.B.A. from Columbia Business School (2024).
- Wechsler is independent under Nasdaq standards and will receive standard non-employee director compensation and equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/0000950170-24-114481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024114481/glto-20241015.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-114481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer